Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(13%)
Results Posted
44%(4 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
3
19%
Ph phase_1
3
19%
Ph phase_2
4
25%
Ph not_applicable
1
6%
Ph phase_3
5
31%

Phase Distribution

3

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
3(18.8%)
Phase 2Efficacy & side effects
4(25.0%)
Phase 3Large-scale testing
5(31.3%)
Phase 4Post-market surveillance
3(18.8%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(2)
Completed(9)
Terminated(2)
Other(3)

Detailed Status

Completed9
unknown3
Active, not recruiting1
Terminated1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (18.8%)
Phase 24 (25.0%)
Phase 35 (31.3%)
Phase 43 (18.8%)
N/A1 (6.3%)

Trials by Status

active_not_recruiting16%
terminated16%
recruiting16%
withdrawn16%
completed956%
unknown319%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT02368886Phase 2

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Completed
NCT05364515Phase 3

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva

Withdrawn
NCT04364555Phase 2

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

Active Not Recruiting
NCT05724446Phase 3

Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population

Recruiting
NCT04649697Phase 3

Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients

Unknown
NCT03926377Phase 4

Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid

Unknown
NCT04249076Phase 3

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

Completed
NCT04246801Phase 3

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)

Completed
NCT03592342Phase 2

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Completed
NCT03535233Phase 4

Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata

Completed
NCT03026478Phase 2

Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus

Unknown
NCT02936492Phase 1

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Terminated
NCT02416531Not Applicable

Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser

Completed
NCT01381445Phase 1

A Study Assessing GW870086's Potential to Cause Skin Thinning

Completed
NCT02940002Phase 1

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Completed
NCT00828464Phase 4

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16